Skip to main content
. 2021 Sep 24;12:645437. doi: 10.3389/fphar.2021.645437

TABLE 3.

The adverse event and severe adverse events of the SS-1 trial for patients with Sjögren’s syndrome.

Adverse event Number Association
Elevation of serum transaminases 5 1: probable related
2: placebo period
1: definitely not related (Not yet taking the drug)
1: unlikely related
Itchy skin 1 unlikely related
Dysuria 1 placebo period
Upper abdominal pain 1 unlikely related
Herpes simplex 1 definitely not related
Acute conjunctivitis 1 placebo period
Urinary tract infections 1 unlikely related
Common cold 1 placebo period
Severe adverse event
Acute appendicitis 1 unlikely related
Bacteremia 1 definitely not related